PCN66 Cost-Effectiveness of Denosumab Versus Zoledronic Acid for Skeletal-Related Event (SRE) Reduction in Bone-Metastatic Prostate Cancer (mPC) in the UK

✍ Scribed by M.F. Botteman; J.A. Carter; P. Fishman; D. Chandiwana; M. Bains; S.J. Snedecor

• Book ID: 119312352
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 71 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.08.2106